Legal & General Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-355,278
Closed -$315K 3417
2022
Q4
$315K Buy
355,278
+25,325
+8% +$22.4K ﹤0.01% 2452
2022
Q3
$518K Sell
329,953
-16,028
-5% -$25.2K ﹤0.01% 2335
2022
Q2
$696K Buy
345,981
+77,177
+29% +$155K ﹤0.01% 2268
2022
Q1
$627K Buy
268,804
+3,143
+1% +$7.33K ﹤0.01% 2336
2021
Q4
$1.24M Buy
265,661
+24,990
+10% +$116K ﹤0.01% 2189
2021
Q3
$1.84M Buy
240,671
+173,764
+260% +$1.33M ﹤0.01% 2060
2021
Q2
$649K Buy
66,907
+6,544
+11% +$63.5K ﹤0.01% 2294
2021
Q1
$500K Sell
60,363
-1,962
-3% -$16.3K ﹤0.01% 2305
2020
Q4
$425K Buy
62,325
+7,106
+13% +$48.5K ﹤0.01% 2292
2020
Q3
$616K Sell
55,219
-2,136
-4% -$23.8K ﹤0.01% 2158
2020
Q2
$360K Buy
57,355
+36,033
+169% +$226K ﹤0.01% 2239
2020
Q1
$39K Sell
21,322
-5,083
-19% -$9.3K ﹤0.01% 2685
2019
Q4
$89K Buy
26,405
+2,916
+12% +$9.83K ﹤0.01% 2631
2019
Q3
$50K Hold
23,489
﹤0.01% 2737
2019
Q2
$80K Hold
23,489
﹤0.01% 2605
2019
Q1
$111K Buy
23,489
+3,670
+19% +$17.3K ﹤0.01% 2459
2018
Q4
$47K Buy
19,819
+3,437
+21% +$8.15K ﹤0.01% 2722
2018
Q3
$72K Buy
16,382
+3,414
+26% +$15K ﹤0.01% 2609
2018
Q2
$93K Buy
+12,968
New +$93K ﹤0.01% 2521
2017
Q2
Sell
-9,032
Closed -$36K 3401
2017
Q1
$36K Sell
9,032
-504
-5% -$2.01K ﹤0.01% 2935
2016
Q4
$48K Buy
9,536
+4,628
+94% +$23.3K ﹤0.01% 2900
2016
Q3
$37K Sell
4,908
-946
-16% -$7.13K ﹤0.01% 2660
2016
Q2
$34K Hold
5,854
﹤0.01% 2669
2016
Q1
$31K Hold
5,854
﹤0.01% 2582
2015
Q4
$51K Hold
5,854
﹤0.01% 2453
2015
Q3
$48K Hold
5,854
﹤0.01% 2473
2015
Q2
$100K Buy
+5,854
New +$100K ﹤0.01% 2114